MANGOCEUTICALS, INC. Files 8-K Report
Ticker: MGRX · Form: 8-K · Filed: Oct 3, 2024 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, financial-reporting
TL;DR
MANGOCEUTICALS, INC. filed an 8-K, likely routine financial updates.
AI Summary
On October 3, 2024, MANGOCEUTICALS, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or significant business events were detailed in the provided excerpt.
Why It Matters
This filing indicates MANGOCEUTICALS, INC. is providing updates or submitting required financial documents to the SEC, which is standard corporate disclosure.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events or financial distress.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- October 3, 2024 (date) — Date of Earliest Event Reported
- Texas (location) — State of Incorporation
- 001-41615 (other) — SEC File Number
- 87-3841292 (other) — IRS Employer Identification No.
- 15110 N. Dallas Parkway , Suite 600 Dallas , Texas 75248 (address) — Principal executive offices
- (214) 242-9619 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by MANGOCEUTICALS, INC. in this 8-K filing?
The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported, only that this item is included.
What "Financial Statements and Exhibits" are being filed by MANGOCEUTICALS, INC.?
The excerpt indicates that "Financial Statements and Exhibits" are part of the filing, but does not specify which ones.
When was the earliest event reported in this 8-K filing for MANGOCEUTICALS, INC.?
The earliest event reported in this 8-K filing for MANGOCEUTICALS, INC. was on October 3, 2024.
What is the principal executive office address for MANGOCEUTICALS, INC.?
The principal executive offices of MANGOCEUTICALS, INC. are located at 15110 N. Dallas Parkway, Suite 600, Dallas, Texas 75248.
What is the SEC file number for MANGOCEUTICALS, INC.?
The SEC file number for MANGOCEUTICALS, INC. is 001-41615.
Filing Stats: 849 words · 3 min read · ~3 pages · Grade level 12 · Accepted 2024-10-03 08:30:33
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 Par Value Per Share MGRX The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 22KB
- 0001493152-24-039300.txt ( ) — 246KB
- mgrx-20241003.xsd (EX-101.SCH) — 3KB
- mgrx-20241003_lab.xml (EX-101.LAB) — 33KB
- mgrx-20241003_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MANGOCEUTICALS, INC. Date: October 3, 2024 By: /s/ Jacob D. Cohen Jacob D. Cohen Chief Executive Officer